CLINICAL_TRIALS
trial_result
· 2017-12-12
Clinical Trial Update: Targeting Oxidative Stress in Chronic Beryllium Disease [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial investigating therapies targeting oxidative stress in Chronic Beryllium Disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Jewish Health | Conditions: Chronic Beryllium Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-12-12